Sentences with phrase «dollar programs on»

Not exact matches

Segura won't put a dollar figure on what Completely Normal did for his career (he retained 35 percent ownership of the program), but he says it paved the way for bigger paydays — and that's been the case for other comics as well.

Over the past 30 years, policymakers from around the United States have spent countless hours and numerous dollars on programs, policies, and incentives to create venture - capital clusters and to stimulate investments in their cities and regions.

«If a charity's financials show that just pennies on the dollar are going towards the programs they support, that's a red flag and you should probably direct your donations somewhere else,» she says.

Samantha Godfrey, CEO and co-founder of San Diego - based Pharmly, a pharmaceutical bidding marketplace that graduated from the program in June, says her company benefited from mentors who gave guidance for which she would have paid top dollar had she been working on her own, as well as from $ 60,000 in credit for Microsoft's Azure cloud platform.

«Most business owners don't realize they could be saving thousands of dollars per month if they only used the right systems, programs and expense optimization tactics,» explains Gerber, who along with Paugh recently co-founded SimpleBusiness, an absolute must - have membership for every small business owner, startup founder and freelancer that saves time, headaches and money on everyday business - related expenses and name - brand services (more on that below).

The channel was kind of on auto - pilot while it regrouped itself from some earlier difficulties back in 2008 and 2009, so it was just a question of putting in the dollars for programming.

Gone are the days of spending all the program dollars on search engine marketing.

The study estimated that each dollar the company spent on the disease management program saved $ 3.78, compared to savings of only 48 cents for the lifestyle segment.

Adding to the pressure on Dollar General were cuts in food - stamp programs as seven states, all governed by Republicans, ended benefits earlier than they had to.

Lauren Bush, founder of FEED, the initiative to fight world hunger on behalf of the UN World Food Program, was only a student when she started her company, but through her determination and willingness to adapt she was able to build a multi-million dollar business.

Instead of being critical and coveting more equalization dollars, they need to constrain spending on entitlement programs that are no longer sustainable, and keep taxes low.

It announced a $ 138 - million relief program to buy back ABCP at 100 % on the dollar (plus interest) from clients who have $ 1 million or less invested in the toxic paper.

Instead of spending tax dollars on programs such as welfare, food stamps, Medicare and Social Security for some of the population, give an equal amount to everyone and be done with it.

That billion dollars the government is spending is from Medicare Part D, a program for elderly Americans (not infants) that spent more than $ 500 million on the drug in 2015 alone.

* Evaluate the percentage of donor dollars spent directly on program expenses.

Shares of Dollar Tree Inc. and Dollar General Corp. both dropped on Monday after President Donald Trump unveiled the plan, which would slash cash payments and substitute them with packages of food — potentially one of the biggest shake - ups in the history of the Supplemental Nutrition Assistance Program, or SNAP.

The euro jumped against the dollar on Thursday after the European Central Bank said it could revisit its communication stance in early 2018, boosting expectations that policymakers are preparing to reduce their vast monetary stimulus program.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

As secretary, Price criticized the Medicaid health program for low - income people, saying it doesn't deliver results commensurate with the hundreds of billions of dollars taxpayers spend on it.

It's a loyalty program that's made it easier than ever to be loyal, but the brand's raised the stakes: On certain days you can earn double stars for every dollar you spend, increasing the allure of that Java Chip Frappuccino you've been craving.

After McDonald's backed away from its Dollar Menu a few years ago, «we weren't as competitive as we needed to be on value and so what you're going to see from us next year is us being really fully competitive with our near - in competitors with a value program,» Kempczinski said.

On one hand, the streaming service has added billions of new dollars into the television business in recent years, building up its offerings by licensing programs from TV groups.

Both cards have similar purchase rewards programs, although you earn three points per dollar on airfare and two points on gas and groceries.

In total, obviously, that program went on to raise hundreds and millions of dollars.

Eyes on the Dollar is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to amazProgram, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to amazprogram designed to provide a means for sites to earn advertising fees by advertising and linking to amazon.com.

«In addition this government reduced taxes on corporations by fifty billion dollars, which in the short and long term will deprive future governments» ability to improve programs and balance budgets.

The executives» corner - cutting on compliance adds to the embarrassment and regulatory headaches for Zurich - based Credit Suisse, which has had to pay billions of dollars of fines to U.S. authorities in recent years over a wide range of allegations, including mis - selling of mortgage - backed securities, deficiencies in its anti-money-laundering program, front - running clients on foreign - exchange trades and violating U.S. sanctions by secretly funneling money from Iran through American banks.

Having thousands of dollars repaid on your behalf is well worth the effort of finding repayment programs you're eligible for, so be sure to conduct thorough research — and apply carefully to maximize your chances of success.

Years after a national task force recommended enacting anti-spam legislation, the Canadian bill finally established strict rules for electronic marketing and safeguards against the installation of unwanted software programs on personal computers, all backed by tough multi-million dollar penalties.

In fact, over a decade ago, I was told by my peers of the exact same scam, described by neuro - linguistic programming expert Derren Brown of a fool - proof system that could predict the winner of every horse race around the world, used by Wall Street financial consultants on unsuspecting prospects to successfully gather millions of dollars of AUM.

Forms of compensation that do not qualify is any compensation that incentivizes the advisor to make the specific recommendation — like trips, awards programs, productions bonuses, and marketing dollars based on production or performance.

When a board of directors authorizes a share repurchase program, it typically states either the number of shares the company is interested in buying back or a dollar amount it will spend on its stock buyback.

When you participate in our Home Loan Affinity Program, you can offer your employees or members a way to save on their home loan every single month — an opportunity that could be worth thousands of dollars over the life of the loan.

Brands, especially from eCommerce industry, are spending 20 % more dollars on Facebook advertising now, according to the report published by Nanigans, a company that provides software for brands to automate their Facebook ad buys and that is a part of Facebook's Marketing Developers program.

The US dollar looks to be on target for its best weekly performance against the Japanese yen since early June, despite yesterday's slip on the back of concerns for the stability of the US economy with the potential tapering of the Federal Reserve's $ 85 billion a month bond purchasing program once again coming to the forefront of investors minds.

But as cities, counties and states compete for economic development, spending on such programs nationwide has climbed into the billions of dollars, even in an era of fiscal austerity.

Finally, this is one piece of advice that is likely to do you well if you've chosen to build a long - term, conservative investment portfolio based upon dollar cost averaging, low - cost ownership methods such as a dividend reinvestment program (also known as a DRIP account), and do not expect to retire or need the funds for ten years or more, the best course of action based upon historical experience may be to go on autopilot.

Program trading, as it was called, began to take over and automate the stock trading business, which, coupled with investor fears stemming from the government's intent to remove tax benefits and devalue the dollar, sparked a run on the market that no one really foresaw.

Cardholders also receive a competitive rewards program that features 1.5 points per dollar spent on purchases, and each point is worth one cent statement credit towards travel purchases.

Jay introduces the program, gives updates on sponsors, and Michael Oliver supplies updates on his call for the dollar, gold and more.

While the card doesn't come with a robust rewards program like Chase Ultimate Rewards, it offers a high yield on Marriott purchases, and an anniversary bonus which can be worth hundreds of dollars.

For every dollar it spent on its tuition reimbursement program, it got its dollar back and saved an additional $ 1.29 in talent management costs, report the Lumina Foundation.

Imagine the impact on today's gross domestic product if millions of low - wage working Americans, who got short - term help from a social service program with long - range goals, started earning a few more extra dollars.

While I agree that we need separation of church and state... It is a stretch to say that our politicians are establishing a theocracy... on the other hand, you are turning a bling eye to the billions of dollars that have gone into hospitals, universities, feed the hunger programs... All funded by people of faith.

Although billions of dollars are being expended annually on family planning services in less - developed countries, and such programs have been promoted by various governments at the national level for four decades, there are only a few studies that have attempted to measure the demographic and health impact of family planning against a «control group» — a similar area which lacks the service.

Spending on pet programs as a new president might wish, but achieving balance by means of cutting spending from the pet Bush or Republican earmark programs, of which there is hundreds of billions of dollars» worth.

The fact that poverty remains a serious problem in the United States after the federal government has spent $ 22 trillion dollars on social welfare programs over the past fifty years should have taught us all something about the complex problems of empowering the poor.

At least, I can choose which ministries I want to support with my money... I don't get to choose which wasteful programs my tax dollars are wasted on... It's just a hunch, but I'm willing to bet that you are a tax taker and not a tax payer... and I mean income tax not sales tax, car tax, and other nominal taxes.

A simple, small, symbolic, but concrete gesture of protest to the $ 200,000 dollars a minute being spent on militarism while programs that support life go bankrupt.»

Santa Claus is part of a Indocrination program that has been on - going from 500 years ago to maintain the status quo of white supremacy, people grow up totally conflicted when they realize their hard earned dollars is the real Santa claus that they willingly spend and too their kids continue to support the Lie.